drugset / Trial / NCT03326505
Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims at expanding Umbilical Cord derived Mesenchymal Stem Cells (MSCs) to a clinical scale according to Good Laboratory Practice and study its efficacy when compared to a Supervised Physical Therapy Program alone.
Timeline
- Start
- 2017-09-25
- Primary completion
- 2020-01-25
- Completion
- 2020-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | mesenchymal stem cells | Cell therapy | — | Intrathecal |